It is exciting to me that we have not one but two INDs coming. Prurisol and Brilacidin oral mucositis. I know we are all following the company ever so closely here, but there are many who surf the biotech sector looking for announcements like this as catalysts to move in to a stock. I agree, the IND filings could move the price nicely, time will tell. Just happy that Leo is keeping things moving along. Seems like so much is happening rapidly now with all the Kevetrin studies ongoing, Prurisol IND coming up quicker than I anticipated, and of course all the Brilacidin developments. Not to mention the whole "but its just 2 guys!!" argument just got thrown way the hell out the window.